Ipilimumab/NivolumabAutoimmune-hepatitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72276-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：167 / 167

相关论文

共 50 条

[31] Ipilimumab/nivolumabAutoimmune thyroiditis leading to thyrotoxicosis and delirium: case report
Reactions Weekly, 2025, 2050 (1) : 282 - 282
[32] Ipilimumab/nivolumabAutoimmune encephalitis: 2 case reports
Reactions Weekly, 2016, 1620 (1) : 101 - 101
[33] Ipilimumab/nivolumabAutoimmune encephalitis: 2 case reports
Reactions Weekly, 2019, 1782 (1) : 186 - 186
[34] Ipilimumab/nivolumabEnteritis and hepatitis: case report
Reactions Weekly, 2018, 1696 (1) : 214 - 214
[35] Ipilimumab/NivolumabImmune hepatitis: case report
Reactions Weekly, 2024, 2037 (1) : 219 - 219
[36] Ipilimumab/nivolumabAutoimmune hypophysitis
Reactions Weekly, 2023, 1985 (1) : 271 - 271
[37] NivolumabAutoimmune gastritis: case report
Reactions Weekly, 2022, 1900 (1) : 254 - 254
[38] NivolumabAutoimmune encephalitis: case report
Reactions Weekly, 2018, 1684 (1) : 194 - 194
[39] NivolumabAutoimmune thyroiditis: case report
Reactions Weekly, 2020, 1795 (1) : 206 - 206
[40] NivolumabAutoimmune diabetes: case report
Reactions Weekly, 2017, 1651 (1) : 239 - 239

← 1 2 3 4 5 →